ArticleFrontiers in pharmacology2025

Neurotherapeutics across blood-brain barrier: screening of BBB-permeable and CNS-active molecules for neurodegenerative disease.

D Mohan Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.